Speakers

Simon joined Johnson and Johnson as Neuroscience Disease Area Stronghold leader for neurodegenerative disorders in 2018 and is now Global Lead for Neuroscience Discovery and Translational Science. Prior to moving to industry, he was Professor of Translational Neuroscience at Oxford University where he founded the ARUK Dementia Drug Discovery Institute with Chas Bountra, and before that was at King’s College London where he led the Biomedical Research Centre for Mental Health and was Director of Research at King’s Health Partners. His research interests are in the mechanisms of Alzheimer’s Disease and in the search for biomarkers; both increasingly utilizing Big Data and necessitating advanced analytics including AI/ML and then using these insights in drug discovery and experimental medicine; He studied Microbiology at Sheffield University, Medicine at Southampton University and his PhD was from the University of London for research on the role of GSK3 in the phosphorylation of tau. He was knighted for services to Neuroscience research in 2017.